303 related articles for article (PubMed ID: 23811938)
1. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
[TBL] [Abstract][Full Text] [Related]
2. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Liver Int; 2014 Sep; 34(8):1216-23. PubMed ID: 24267737
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
[TBL] [Abstract][Full Text] [Related]
4. Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.
Lee HW; Yoo EJ; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Han KH
Am J Gastroenterol; 2014 Aug; 109(8):1241-9. PubMed ID: 24957159
[TBL] [Abstract][Full Text] [Related]
5. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
Chon YE; Park JY; Myoung SM; Jung KS; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH
Am J Gastroenterol; 2017 Jun; 112(6):882-891. PubMed ID: 28374814
[TBL] [Abstract][Full Text] [Related]
6. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
7. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
Wang HW; Lai HC; Hu TH; Su WP; Lu SN; Lin CH; Hung CH; Chuang PH; Wang JH; Lee MH; Chen CH; Peng CY
J Gastroenterol Hepatol; 2019 Feb; 34(2):442-449. PubMed ID: 29968933
[TBL] [Abstract][Full Text] [Related]
8. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
Kim SU; Lee JH; Kim DY; Ahn SH; Jung KS; Choi EH; Park YN; Han KH; Chon CY; Park JY
PLoS One; 2012; 7(5):e36676. PubMed ID: 22574212
[TBL] [Abstract][Full Text] [Related]
9. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
10. Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.
Kim BK; Oh HJ; Park JY; Kim DY; Ahn SH; Han KH; Park Y; Yoo EJ; Park YN; Kim SU
Liver Int; 2013 Feb; 33(2):180-9. PubMed ID: 23295050
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment.
Wu SD; Liu LL; Cheng JL; Liu Y; Cheng LS; Wang SQ; Ma W; Chen LP; Tseng YJ; Wang JY; Shen XZ; Jiang W
Clin Exp Med; 2018 Aug; 18(3):433-443. PubMed ID: 29696462
[TBL] [Abstract][Full Text] [Related]
12. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
13. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis.
Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW
Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
Shin SH; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim BK
Liver Int; 2015 Mar; 35(3):1054-62. PubMed ID: 24930484
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Song KJ; Park YN; Han KH
Hepatology; 2015 Jun; 61(6):1851-9. PubMed ID: 25643638
[TBL] [Abstract][Full Text] [Related]
16. Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response.
Lee HW; Chon YE; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Jung KS; Park YN; Han KH
Gut Liver; 2016 May; 10(3):429-36. PubMed ID: 26347515
[TBL] [Abstract][Full Text] [Related]
17. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
19. Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L; Sánchez-Conde M; Rincón D; Miralles P; Aldámiz-Echevarría T; Carrero A; Tejerina F; Díez C; Bellón JM; Bañares R; Berenguer J
Clin Infect Dis; 2014 Mar; 58(5):713-8. PubMed ID: 24265358
[TBL] [Abstract][Full Text] [Related]
20. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
